Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 21-30 of 78

Page
per page
  1. Azelnidipine
    B1414 Azelnidipine
    Summary: L-type calcium channel blocker;antihypertensive
      ≥27.15 mg/mL
  2. Zonisamide sodium
    B1231 Zonisamide sodium
    Summary: Antiepileptic drug
      Soluble in DMSO
  3. Felodipine
    B1416 Felodipine
    Summary: Selective L-type Ca2+ channel blocker
      insoluble in H2O; ≥17.65 mg/mL
  4. Tetracaine HCl
    B1413 Tetracaine HCl
    Summary: Anaesthetic and allosteric inhibitor
      ≥10.85 mg/mL
  5. Nitrendipine
    B1393 Nitrendipine
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: Calcium channel blocker
      insoluble in H2O; ≥13.7 mg/mL
  6. Amlodipine
    B1410 Amlodipine
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: Calcium channel blocker
      insoluble in H2O; ≥17.7 mg/mL
  7. Amlodipine Besylate
    B1411 Amlodipine Besylate
    Summary: Block of L-type calcium channel
      ≥26.05 mg/mL
  8. Flunarizine 2HCl
    B1412 Flunarizine 2HCl
    Summary: Calcium entry blocker
  9. Lacidipine
    B1417 Lacidipine
    Summary: L-type calcium channel blocker
      ≥21.25 mg/mL
  10. Benidipine HCl
    B1409 Benidipine HCl
    Summary: Calcium channel blocker
      ≥21.8 mg/mL

Items 21-30 of 78

Page
per page